FOI release

Request for Information - FOI

Some or all of the information requested was not provided because we didn't hold it.

Case reference FOI2025/00111

Received 7 February 2025

Published 25 April 2025

Request

Request for Information. Product Name: 1. Trientine 250mg Caps 2. Trientine 200mg Caps 3. Trientine 300mg Caps 4. Trientine 500mg Caps 5. Acetazolamide Prolonged Release Caps 250mg & 500mg 6. Probenecid Tabs 500mg 7. Lorazepam Injection 4mg/ml & 2mg/ml We are planning to launch above mentioned product in UK market. We understand that for some of these products MAs are not approved in UK and are imported on named patient basis. Others are approved but limited consumption. We hereby request you to kindly share below information 1. SKU and Volume ( packs) consumed in UK market in last three years 2. Number of import notification along with supplier name and volume ( packs) in last three years This information will help us to evaluate it this would be commercially viable to launch a licensed product.

Response

see attached

Documents

• FOI2025_00111 redacted for publication.pdf (111.5 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.